13F filer · CIK 1344551 ↗
Assetmark, Inc
You are looking at Q3 2021. See the latest, Q3 2026 →
Reported value
$22.32B
+3.5% on the quarter before
Positions
1,469
205 new · 101 sold out
Top 10
28.0%
of the value
Est. gain
−$126.0M
on stocks held all quarter
Est. return
−0.7%
on those stocks since Q2 2021
Positions as of Sep 30, 2021, from Assetmark, Inc's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 45% of the reported value, each sized by its share, colored by what the fund did with it since Q2 2021. Striped tiles are options.
Largest buys
Since Q2 2021, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Nushares ETF Tr Nuveen Enhnc Yld~$172.1MAdded · 0.0% → 0.8%+6,933,445 shares
- Ishares Tr Gov/Cred Bd ETF~$172.0MAdded · 0.0% → 0.8%+1,410,808 shares
- Ishares Tr Usd Inv Grde ETF~$171.6MAdded · 0.1% → 0.8%+2,855,469 shares
- Ishares Tr 10-20 Yr Trs ETF~$168.9MAdded · 0.0% → 0.8%+1,148,292 shares
- Ishares Tr Residential Mult~$151.6MNew · 0.0% → 0.7%+1,771,270 shares
- Ishares Tr Core S&P500 ETF~$117.7MAdded · 0.0% → 0.5%+273,311 shares
- Ishares Tr Iboxx Inv Cp ETF~$110.9MAdded · 2.1% → 2.5%+833,879 shares
- Alphabet~$102.7MAdded · 0.2% → 0.7%+38,418 shares
- Laboratory Corp Amer Hldgs Com New~$102.4MAdded · 0.0% → 0.5%+363,904 shares
- Ishares Tr S&P Mc 400vl ETF~$86.0MAdded · 0.0% → 0.4%+834,678 shares
Largest sells
Since Q2 2021, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Ishares Tr Us Br Del Se ETF~$160.2MCut · 0.7% → 0.0%−1,538,045 shares
- SPDR Ser Tr S&P Ins ETF~$152.7MCut · 0.7% → 0.0%−3,951,820 shares
- SPDR Ser Tr S&P Bk ETF~$152.5MCut · 0.7% → 0.0%−2,932,791 shares
- Ishares Tr Us Hlthcr Pr ETF~$150.9MCut · 0.7% → 0.0%−585,974 shares
- Ishares Tr S&P Mc 400gr ETF~$132.6MCut · 0.4% → 0.0%−1,060,451 shares
- Proshares Tr Pshs Ult S&P 500~$118.3MCut · 1.0% → 0.4%−987,323 shares
- Select Sector SPDR Tr Sbi Materials~$94.0MCut · 0.5% → 0.0%−1,188,342 shares
- Ishares Tr Rus 1000 Val ETF~$91.7MCut · 0.4% → 0.0%−590,128 shares
- Fidelity Merrimack Str Tr Ltd Trm Bd ETF~$84.7MCut · 0.4% → 0.0%−1,608,573 shares
- Ishares Tr 0-5 Yr Tips ETF~$84.2MCut · 0.4% → 0.0%−797,016 shares
Holdings
As of Sep 30, 2021. Changes are in shares against Jun 30, 2021, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Vanguard Index Fds S&P 500 ETF ShsETF · shares +6.8% · price +0.2% | 5.6% | $1.26B | +$2.6M | ||||||||
| Vanguard World Fd Mega Grwth IndETF · shares +6.2% · price +1.5% | 5.0% | $1.11B | +$15.2M | ||||||||
| Vanguard World Fd Mega Cap Val ETFETF · shares +8.6% · price −1.8% | 3.6% | $812.1M | −$13.5M | ||||||||
| Ishares Tr Iboxx Inv Cp ETFETF · shares +25% · price −1.0% | 2.5% | $561.6M | −$4.5M | ||||||||
| Ishares Tr Core Msci EafeETF · shares +5.8% · price −0.8% | 2.2% | $486.7M | −$3.8M | ||||||||
| Ishares Tr 20 Yr Tr Bd ETFETF · shares +15% · price −0.0% | 2.1% | $458.7M | −$83,342 | ||||||||
| Vanguard Index Fds Sm Cp Val ETFETF · shares +8.4% · price −2.5% | 1.9% | $431.2M | −$10.3M | ||||||||
| Ishares Tr Iboxx Hi Yd ETFETF · shares +6.5% · price −0.6% | 1.8% | $409.6M | −$2.4M | ||||||||
| Ishares Inc Core Msci EmktETF · shares +5.2% · price −7.8% | 1.7% | $379.4M | −$30.5M | ||||||||
| Ishares Tr 3 7 Yr Treas BdETF · shares +4.7% · price −0.3% | 1.6% | $350.6M | −$925,352 | ||||||||
| Vanguard Index Fds Mcap Gr IdxvipETF · shares +6.8% · price −0.0% | 1.4% | $301.7M | −$59,453 | ||||||||
| Ishares Tr Ishs 5-10yr InvtSHS · shares +4.5% · price −0.8% | 1.4% | $301.6M | −$2.2M | ||||||||
| Vanguard Charlotte Fds Total Int Bd ETFETF · shares +4.8% · price −0.2% | 1.3% | $291.0M | −$682,006 | ||||||||
| Ishares Tr Us Treas Bd ETFETF · shares +6.5% · price −0.3% | 1.3% | $290.8M | −$720,133 | ||||||||
| Vanguard Scottsdale Fds Mtg-Bkd Secs ETFETF · shares +1.3% · price −0.2% | 1.3% | $290.7M | −$431,294 | ||||||||
| SPDR Ser Tr Portfolio S&P500ETF · shares −2.4% · price +0.3% | 1.3% | $287.5M | +$740,907 | ||||||||
| SPDR Ser Tr Bloomberg BrclysETF · shares −3.5% · price −0.5% | 1.3% | $285.5M | −$1.6M | ||||||||
| Vanguard Index Fds Mcap Vl IdxvipETF · shares +9.0% · price −0.6% | 1.3% | $283.2M | −$1.7M | ||||||||
| Vanguard Index Fds Extend Mkt ETFETF · shares +5.8% · price −3.3% | 1.1% | $256.2M | −$8.3M | ||||||||
| Vanguard Index Fds Value ETFETF · shares +0.7% · price −1.5% | 1.1% | $252.2M | −$3.9M | ||||||||
| Vanguard Index Fds Sml Cp Grw ETFETF · shares +6.0% · price −3.3% | 1.1% | $247.6M | −$8.0M | ||||||||
| SPDR Ser Tr Portfolio Sh TsrETF · shares −5.2% · price −0.0% | 1.1% | $244.0M | −$79,847 | ||||||||
| Vanguard Bd Index Fds Total Bnd MrktETF · shares +15% · price −0.5% | 1.0% | $233.7M | −$1.0M | ||||||||
| AppleCOM · shares +4.3% · price +3.3% | 1.0% | $230.3M | +$7.1M | ||||||||
| MicrosoftCOM · shares +2.2% · price +4.1% | 1.0% | $225.5M | +$8.6M | ||||||||
| Total · 1,469 positions | 100% | $22.32B | −$126.0M |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q2 2021 to Q3 2021: 1,198 stocks held throughout, down $126.0M (−0.7%).
- Vanguard World Fd Mega Grwth Ind+$15.2M+1%
- Bio Rad Labs Inc Cl A+$14.1M+16%
- Quanta Services+$11.0M+26%
- Pfizer Inc Com+$9.5M+10%
- Microsoft+$8.6M+4%
- Vanguard Index Fds Sm Cp Val ETF−$10.3M−3%
- Newmont Corp Com−$10.8M−14%
- SPDR Index Shs Fds S&P China ETF−$10.8M−17%
- Vanguard World Fd Mega Cap Val ETF−$13.5M−2%
- Ishares Inc Core Msci Emkt−$30.5M−8%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 5 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q3 2026 | Oct 21, 2026 | $59.48B+2% | SEC ↗ |
| Q2 2026 | Jul 30, 2026 | $58.17B+19% | SEC ↗ |
| Q1 2026 | May 6, 2026 | $49.04B+0% | SEC ↗ |
| Q4 2025 | Jan 23, 2026 | $49.04B+5% | SEC ↗ |
| Q3 2025 | Nov 6, 2025 | $46.65B+10% | SEC ↗ |
| Q2 2025 | Aug 4, 2025 | $42.36B+16% | SEC ↗ |
| Q1 2025 | May 6, 2025 | $36.41B−1% | SEC ↗ |
| Q4 2024 | Feb 6, 2025 | $36.81B+5% | SEC ↗ |
| Q3 2024 | Nov 1, 2024 | $34.92B+8% | SEC ↗ |
| Q2 2024 | Aug 13, 2024 | $32.33B+5% | SEC ↗ |
| Q1 2024 | May 7, 2024 | $30.76B+11% | SEC ↗ |
| Q4 2023 | Feb 9, 2024 | $27.67B+11% | SEC ↗ |
| Q3 2023 | Oct 27, 2023 | $25.01B−2% | SEC ↗ |
| Q2 2023 | Aug 11, 2023 | $25.49B+5% | SEC ↗ |
| Q1 2023 | May 5, 2023 | $24.19B+5% | SEC ↗ |
| Q4 2022 | Feb 10, 2023 | $23.07B+8% | SEC ↗ |
| Q3 2022 | Nov 1, 2022 | $21.39B−4% | SEC ↗ |
| Q2 2022 | Aug 3, 2022 | $22.31B−7% | SEC ↗ |
| Q1 2022 | May 13, 2022 | $23.89B−2% | SEC ↗ |
| Q4 2021 | Feb 14, 2022 | $24.34B+9% | SEC ↗ |
| Q3 2021 | Nov 12, 2021 | $22.32B+4% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $21.56B+11% | SEC ↗ |
| Q1 2021 | May 14, 2021 | $19.39B+8% | SEC ↗ |
| Q4 2020 | Feb 10, 2021 | $17.95B+16% | SEC ↗ |
| Q3 2020 | Nov 13, 2020 | $15.50B+11% | SEC ↗ |
| Q2 2020 | Aug 11, 2020 | $13.98B+18% | SEC ↗ |
| Q1 2020 | May 12, 2020 | $11.81B−10% | SEC ↗ |
| Q4 2019 | Feb 11, 2020 | $13.16B+10% | SEC ↗ |
| Q3 2019 | Nov 13, 2019 | $11.95B−3% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $12.27B+11% | SEC ↗ |
| Q1 2019 | May 14, 2019 | $11.07B+7% | SEC ↗ |
| Q4 2018 | Feb 13, 2019 | $10.36B−6% | SEC ↗ |
| Q3 2018 | Nov 13, 2018 | $11.00B+8% | SEC ↗ |
| Q2 2018 | Aug 1, 2018 | $10.18B+5% | SEC ↗ |
| Q1 2018 | May 16, 2018 | $9.66B−0% | SEC ↗ |
| Q4 2017 | Feb 13, 2018 | $9.70B+10% | SEC ↗ |
| Q3 2017 | Nov 8, 2017 | $8.79B+11% | SEC ↗ |
| Q2 2017 | Aug 15, 2017 | $7.95B+4% | SEC ↗ |
| Q1 2017 | Sep 15, 2017 (amended) | $7.61B+12% | SEC ↗ |
| Q4 2016 | Sep 15, 2017 (amended) | $6.81B+4% | SEC ↗ |
| Q3 2016 | Sep 15, 2017 (amended) | $6.58B+11% | SEC ↗ |
| Q2 2016 | Sep 15, 2017 (amended) | $5.95B+4% | SEC ↗ |
| Q1 2016 | Sep 15, 2017 (amended) | $5.73B | SEC ↗ |